Cargando…

Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study

OBJECTIVES: (1) To evaluate the prevalence of polypharmacy (5–9 medicines) and excessive polypharmacy (10+ medicines) and (2) to determine associated demographic and clinical characteristics in an ageing population with intellectual disabilities (IDs). DESIGN: Observational cross-sectional study. SE...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Dwyer, Máire, Peklar, Jure, McCallion, Philip, McCarron, Mary, Henman, Martin C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Geriatric Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823458/ https://www.ncbi.nlm.nih.gov/pubmed/27044582 http://dx.doi.org/10.1136/bmjopen-2015-010505

Ejemplares similares

Medication and supplement use in older people with and without intellectual disability: An observational, cross-sectional study
por: Peklar, Jure, et al.
Publicado: (2017)

The adverse effects of long-term exposure to anticholinergics among people with intellectual disabilities: a scoping review
por: Al Shuhaimi, Lamya, et al.
Publicado: (2022)

Optimising medicines use in older adults with intellectual disability who have epilepsy: challenges and perspectives
por: O’Dwyer, Maire, et al.
Publicado: (2021)

The use of proton pump inhibitors among older adults with intellectual disability: A cross sectional observational study
por: AlMutairi, Hadiah, et al.
Publicado: (2018)

Quantitative examination of the bone health status of older adults with intellectual and developmental disability in Ireland: a cross-sectional nationwide study
por: Burke, Éilish, et al.
Publicado: (2019)

Association of Drug Burden Index with grip strength, timed up and go and Barthel index activities of daily living in older adults with intellectual disabilities: an observational cross-sectional study
por: O’Connell, Juliette, et al.
Publicado: (2019)

An exploration of the consequences of, and coping with loneliness in an ageing intellectual disability population
por: Wormald, Andrew, et al.
Publicado: (2022)

Predictors of Productivity and Leisure for People Aging with Intellectual Disability
por: King, Eilish, et al.
Publicado: (2022)

Sedentary behaviour levels in adults with an intellectual disability: a systematic review protocol
por: Lynch, Louise, et al.
Publicado: (2021)

Sedentary behaviour levels in adults with an intellectual disability: a systematic review and meta-analysis
por: Lynch, Louise, et al.
Publicado: (2022)

The potential for person-centred planning to support the community participation of adults with an intellectual disability
por: McCausland, Darren, et al.
Publicado: (2021)

Staff mental health while providing care to people with intellectual disability during the COVID‐19 pandemic
por: Sheerin, Fintan, et al.
Publicado: (2022)

Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review
por: Cooper, Janine A, et al.
Publicado: (2015)

The impact of COVID‐19 on the social inclusion of older adults with an intellectual disability during the first wave of the pandemic in Ireland
por: McCausland, D., et al.
Publicado: (2021)

Polypharmacy in a Patient With Intellectual and Developmental Disabilities
por: Raj, Rishi, et al.
Publicado: (2022)

Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients
por: Chen, Li‐Ju, et al.
Publicado: (2021)

Irish social policy to family carers of adults with an intellectual disability: A critical analysis
por: Brennan, Damien, et al.
Publicado: (2022)

Impact of COVID-19 Pandemic on Caregivers of People with an Intellectual Disability, in Comparison to Carers of Those with Other Disabilities and with Mental Health Issues: A Multicountry Study
por: Wormald, Andrew, et al.
Publicado: (2023)

Factors associated with excessive polypharmacy in older people
por: Walckiers, Denise, et al.
Publicado: (2015)

Association between polypharmacy and falls in older adults: a longitudinal study from England
por: Dhalwani, Nafeesa N, et al.
Publicado: (2017)

Associations between polypharmacy and treatment intensity for hypertension and diabetes: a cross-sectional study of nursing home patients in British Columbia, Canada
por: McCracken, Rita, et al.
Publicado: (2017)

The impact of COVID-19 on people ageing with an intellectual disability in Ireland: Protocol for a follow-up survey
por: McCarron, Mary, et al.
Publicado: (2021)

Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities
por: Ailabouni, Nagham, et al.
Publicado: (2017)

Adults with Intellectual Disability and Autism Spectrum Disorder: What Is the Evidence around the Use of Polypharmacy
por: McCarthy, Jane M., et al.
Publicado: (2022)

The impact of coronavirus disease 2019 (COVID-19) on older adults with an intellectual disability during the first wave of the pandemic in Ireland
por: McCarron, Mary, et al.
Publicado: (2021)

Effect of deinstitutionalisation for adults with intellectual disabilities on costs: a systematic review
por: May, Peter, et al.
Publicado: (2019)

Effect of deinstitutionalisation on quality of life for adults with intellectual disabilities: a systematic review
por: McCarron, Mary, et al.
Publicado: (2019)

Theoretically derived interventions aimed at improving appropriate polypharmacy in primary care: A systematic review
por: Gorman, Ashleigh, et al.
Publicado: (2022)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study
por: Porter, Bryony, et al.
Publicado: (2019)

Prevalence of polypharmacy in community-dwelling older adults from seven centres in five European countries: a cross-sectional study of DO-HEALTH
por: de Godoi Rezende Costa Molino, Caroline, et al.
Publicado: (2022)

Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland
por: Lonchampt, Sophie, et al.
Publicado: (2021)

Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy
por: Rieckert, Anja, et al.
Publicado: (2018)

Is Excessive Polypharmacy a Transient or Persistent Phenomenon? A Nationwide Cohort Study in Taiwan
por: Wang, Yi-Jen, et al.
Publicado: (2018)

Polypharmacy and Excessive Polypharmacy Among Persons Living with Chronic Pain: A Cross-Sectional Study on the Prevalence and Associated Factors
por: Zahlan, Ghita, et al.
Publicado: (2023)

Associations of ADL and IADL disability with physical and mental dimensions of quality of life in people aged 75 years and older
por: Gobbens, Robbert J.
Publicado: (2018)

Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy
por: Stuhec, Matej, et al.
Publicado: (2022)

Modeling polypharmacy side effects with graph convolutional networks
por: Zitnik, Marinka, et al.
Publicado: (2018)

Polypharmacy in the elderly
por: Golchin, Negar, et al.
Publicado: (2015)

Group cognitive stimulation therapy versus usual care for people with intellectual disabilities and dementia (CST-IDD) in the UK: protocol for a mixed-methods feasibility randomised controlled trial
por: Ali, Afia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5thelc8nt65pgpikloigrikuoo